Speech-Language Pathologists in Central City, KY Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Mrs. Hollie Michelle Tooley, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2310 State Route 2584, Central City, KY 42330 Phone: 270-525-9506 |
 Mcpherson Therapy & Consulting, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 906 W Everly Brothers Blvd, Central City, KY 42330 Phone: 270-608-1829 |
Mrs. Carrie Lynn Mcpherson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 906 W Everly Brothers Blvd, Central City, KY 42330 Phone: 270-608-1829 |
Miss Brooke Michelle Cates, M.S, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 106 Tammy Dr, Central City, KY 42330 Phone: 270-754-4643 |
Shelby Nicole Latham, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 518 Park St, Central City, KY 42330 Phone: 270-977-6707 |
News Archive
CT colonoscopy has 90 percent agreement rate with optical colonoscopy
Nearly 90% of colon polyps greater than or equal to 6 mm in size detected at CT colonoscopy were demonstrated to represent true polyps at subsequent optical colonoscopy (the traditional method of viewing the colon and removing precancerous growths), according to a new study by researchers from the University of Wisconsin Hospital and Clinics in Madison, WI.
Statin therapy reduces cardiovascular disease risk in patients with high sensitivity C-reactive protein
People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein (hsCRP), a blood marker for inflammation, could benefit from cholesterol-lowering therapy even if their cholesterol is already at desirable levels.
New insights into how anti-rejection drug daclizumab (Zenapax) helps MS patients
A research team led by the University of Cincinnati's Bibiana Bielekova, MD, report new insights into the role of the MS drug daclizumab (Zenapax) in the Proceedings of the National Academy of Sciences.
Studying The Effects of Microgravity on Muscle Mass
Studying the effects of gravity on muscle cells can give us an insight into muscle wastage diseases, and potentially guide the development of new therapies. Professor Louis Yuge discusses his research and the cellular changes that occur in response to microgravity.
› Verified 6 days ago
Speech-Language Pathologists
Chiropractors
Optometrists
Podiatrists